GILD vs MNTK · P/E 18, rev $7.80B vs P/E 156, rev $100.4M
Gilead Sciences Inc (GILD) versus Montauk Renewables Inc (MNTK) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Montauk Renewables Inc (MNTK) is a specialty chemicals company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported MNTK revenue for 2026-06-30 was $100.4M. Net income was $231.0K. MNTK currently screens at market cap $222.1M and trailing P/E 156.0.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. MNTK currently screens at market cap $222.1M and trailing P/E 156.0.
Not investment advice. Open the GILD and MNTK stock pages for the full models.
Not investment advice.